Clinical Trial Update: An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating neoadjuvant nivolumab with nab-paclitaxel prior to radical cystectomy in muscle-invasive bladder cancer is being conducted (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• nivolumab (nivolumab)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Muscle-Invasive Bladder Carcinoma | Phase 2 | Status: UNKNOWN